TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 156 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106 | -87.9% | 11,862 | -79.2% | 0.00% | -100.0% |
| Q2 2023 | $873 | -61.7% | 56,900 | -43.9% | 0.00% | -66.7% |
| Q1 2023 | $2,280 | -13.7% | 101,415 | -19.2% | 0.00% | -25.0% |
| Q4 2022 | $2,641 | -84.5% | 125,589 | +17764.7% | 0.00% | – |
| Q2 2022 | $17,000 | -10.5% | 703 | -6.8% | 0.00% | – |
| Q1 2022 | $19,000 | -87.8% | 754 | -85.1% | 0.00% | – |
| Q4 2021 | $156,000 | +44.4% | 5,053 | +12.9% | 0.00% | – |
| Q3 2021 | $108,000 | +10.2% | 4,475 | +23.8% | 0.00% | – |
| Q4 2020 | $98,000 | – | 3,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |